Authors: Brockunier, LL Candelore, MR Cascieri, MA Liu, Y Tota, L Wyvratt, MJ Fisher, MH Weber, AE Parmee, ER

Citation: Ll. Brockunier et al., Human beta(3) adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties, BIOORG MED, 11(3), 2001, pp. 379-382

Authors: Parmee, ER Brockunier, LL He, JF Singh, SB Candelore, MR Cascieri, MA Deng, LP Liu, Y Tota, L Wyvratt, MJ Fisher, MH Weber, AE

Citation: Er. Parmee et al., Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta(3) adrenergic receptor agonists, BIOORG MED, 10(20), 2000, pp. 2283-2286

Authors: Brockunier, LL Parmee, ER Ok, HO Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Tota, L Wyvratt, MJ Fisher, MH Weber, AE

Citation: Ll. Brockunier et al., Human beta 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides, BIOORG MED, 10(18), 2000, pp. 2111-2114

Authors: Gauthier, CA Bagley, JR Brockunier, LL France, CP

Citation: Ca. Gauthier et al., Daily mirfentanil induces (cross-) tolerance to the rate-decreasing effects of morphine and not mirfentanil, BEHAV PHARM, 10(5), 1999, pp. 543-547

Authors: Gerak, LR Moerschbaecher, JM Bagley, JR Brockunier, LL France, CP

Citation: Lr. Gerak et al., Effects of a novel fentanyl derivative on drug discrimination and learningin rhesus monkeys, PHARM BIO B, 64(2), 1999, pp. 367-371